Ron Demuth

Ron Demuth Email and Phone Number

Chariman, Chief Strategist @ Fluxion Therapeutics
San Diego, CA, US
About Ron Demuth

Teal Ventures - Disrupting B2P & B2C Healthcare services with intelligent integrated device platforms, AI-enabled expert systems, business process automation, and blockchain-enabled smart contracts for billing and payment settlements. see: https://teal-ventures.com/teams

Ron Demuth's Current Company Details
Fluxion Therapeutics

Fluxion Therapeutics

View
Chariman, Chief Strategist
San Diego, CA, US
Ron Demuth Work Experience Details
  • Fluxion Therapeutics
    Chariman, Chief Strategist
    Fluxion Therapeutics
    San Diego, Ca, Us
  • Teal Ventures
    Partner & Co_Founder
    Teal Ventures May 2018 - Present
    San Diego, California, Us
  • Torrey Pines Investment
    Partner
    Torrey Pines Investment 2002 - Present
    Torrey Pines Investment is a private, specialty life-science investment company. Torrey Pines has created PPP platforms, incubators and other vehicles for early stage assets with international pharma/biotech partners in CNS, oncology, and virology, to bring them through pharma partnering and M&A. Our philosophy centers on maximizing the potential for capital gains and containing risk of loss by. We focus on unique opportunities in biotech and pharma where we add value in development or regulatory strategy. Torrey Pines Investment will lead, co-lead or syndicate. We are looking for an expected POC on the investment within 3 years.
  • Chemical Diversity (Chemdiv, Inc.)
    Chief Executive Officer (Emeritus)
    Chemical Diversity (Chemdiv, Inc.) Jan 2021 - Dec 2023
    San Diego, Ca, Us
    ChemDiv's chemistry designs, building blocks, and libraries lead the pharmaceutical industry in productivity, novelty, innovation, availability, and ease of access. Our stock-available compound collections are the largest commercially available. We provide pharmatech development for branded, generic, novel formulation, and fixed dose combination drugs. We provide specialized assistance for registration and market access in established, semi-regulated, and emerging markets.
  • Viriom Inc
    Chief Financial Officer (Emeritus)
    Viriom Inc Jul 2009 - Dec 2023
    San Diego, California, Us
    Commercial-stage biopharma with novel therapies and prophylactic medicines for HIV-1 and HBV. First approved drug is Elpida® (elsulfavirine), the best-in-class NNRTI. Pipeline includes novel fixed-dose and single-pill cmbinations; extended-release oral weekly dose; and long-acting injectable for therapy and prophylaxis, and tenofivir prodrug for HIV-1 and HBV.
  • Integrated Genomics, Inc
    General Manager
    Integrated Genomics, Inc 1998 - 2002
  • The University Of Chicago
    Executive Administrator
    The University Of Chicago 1994 - 1998
  • Teachers Academy For Mathematics And Science
    Associate Director
    Teachers Academy For Mathematics And Science 1992 - 1994
  • The University Of Chicago
    Executive Administrator
    The University Of Chicago 1988 - 1992

Ron Demuth Skills

Drug Discovery Biotechnology Pharmaceutical Industry Lifesciences Drug Development Technology Transfer Molecular Biology Commercialization Entrepreneurship Business Strategy Biopharmaceuticals R&d Clinical Development Clinical Trials Genomics Start Ups Oncology Cro Intellectual Property Venture Capital Clinical Research Corporate Development Cancer Marketing Strategy Licensing Immunology Pharmacology Cell Infectious Diseases Assay Development Neuroscience In Vitro Medicinal Chemistry Strategy Business Development Research

Ron Demuth Education Details

  • Pepperdine Graziadio Business School
    Pepperdine Graziadio Business School
  • University Of Chicago
    University Of Chicago
  • University Of Iowa
    University Of Iowa
    Bs
  • Northern Illinois University
    Northern Illinois University
    Neurobiology

Frequently Asked Questions about Ron Demuth

What company does Ron Demuth work for?

Ron Demuth works for Fluxion Therapeutics

What is Ron Demuth's role at the current company?

Ron Demuth's current role is Chariman, Chief Strategist.

What is Ron Demuth's email address?

Ron Demuth's email address is rd****@****ner.com

What is Ron Demuth's direct phone number?

Ron Demuth's direct phone number is +185871*****

What schools did Ron Demuth attend?

Ron Demuth attended Pepperdine Graziadio Business School, University Of Chicago, University Of Iowa, Northern Illinois University.

What skills is Ron Demuth known for?

Ron Demuth has skills like Drug Discovery, Biotechnology, Pharmaceutical Industry, Lifesciences, Drug Development, Technology Transfer, Molecular Biology, Commercialization, Entrepreneurship, Business Strategy, Biopharmaceuticals, R&d.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.